Docetaxel in hormone-sensitive advanced prostate cancer; GENESIS-SEFH evaluation reporta

• Main Authors: Emilio Jesús Alegre del Rey (Author), Rocío Asensi Díez (Author), Juan Carlos García de Paredes Esteban (Author)
• Formato: Livro
• Publicado em: Elsevier, 2017-07-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Prostate cancer (PC) is the most common urogenital malignancy in older men and the second leading cause of death by cancer in men in Europe. Current therapeutic practice considers Androgen Deprivation Therapy (ADT) as first line treatment for clinically localized prostate cancer at high-risk, either...